ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MYMD MyMD Pharmaceuticals Inc

3.18
-0.07 (-2.15%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 38,939
Bid Price 3.13
Ask Price 3.27
News -
Day High 3.3669

Low
2.00

52 Week Range

High
70.50

Day Low 3.1171
Company Name Stock Ticker Symbol Market Type
MyMD Pharmaceuticals Inc MYMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -2.15% 3.18 19:08:35
Open Price Low Price High Price Close Price Prev Close
3.35 3.1171 3.3669 3.33 3.25
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
333 38,939 $ 3.28 $ 127,643 - 2.00 - 70.50
Last Trade Time Type Quantity Stock Price Currency
19:38:08 24 $ 3.15 USD

MyMD Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.97M 2.09M - 0 -8.22M -3.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

MyMD Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MYMD Message Board. Create One! See More Posts on MYMD Message Board See More Message Board Posts

Historical MYMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.853.36692.743.1161,0770.3311.58%
1 Month2.153.502.002.62628,8341.0347.91%
3 Months4.2754.502.003.03340,383-1.10-25.61%
6 Months11.7012.002.006.54968,199-8.52-72.82%
1 Year54.0070.502.0018.01811,948-50.82-94.11%
3 Years128.70298.502.0052.43417,554-125.52-97.53%
5 Years162.90298.502.0057.57435,863-159.72-98.05%

MyMD Pharmaceuticals Description

MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia.

Your Recent History

Delayed Upgrade Clock